Stock Events

Stock Events

Corvus Pharmaceuticals (CRVS) Q2 2025 Earnings

8MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.6

-0.42

-0.25

-0.07

Details

Expected EPS

-0.12

Actual EPS

-0.13

Surprise EPS

-0.01

Surprise Percent

+8.33%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.13 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.